the Editor's Desk
Edwina J. Popek, DO
I hope that the new year has found everyone
in good health and will bring everyone good fortune. I have managed to
keep one of my New Year’s resolutions until today. Oh well that was two
weeks more than I was able to do last year. Looking forward to seeing
everyone in Boston. Please take a look through this newsletter as there
are items of interest to those of you who will be attending. “Research
on Bow Ties Puts Wearers on Edge” was the title of a recent column, by
John T. Malloy who writes about how clothing projects an image to those
with whom we come in contact. Surveys conducted recently and 20 years ago
show that “most people do not trust male bow-tie wearers.” Bow-tie
wearers are reported to see themselves as rebels, or at least out-siders
and the public feels that they are less predictable than the average tie
wearer. This is due in part to the fact that bow ties are traditionally
worn by men in professions that are outside the mainstream; clowns,
college professors, and social and art critics (and pediatric
pathologists). Bow-tie wearers announce that they are different, and they
are proud of it, but must be willing to accept that “people will not
James E. Dimmick, MD
This will be the final contribution to the newsletter during my term of
office. I thank the very many members who tackled the old and new agenda
of the Society and made my time enjoyable. The year has had Jerkyll and
Hyde qualities, and has passed at a hectic pace. On the home front
managerialists have kept up a vigorous assault on the practice and
academia of pathology, nothing new to most of us, but nevertheless
consuming otherwise valuable energy. Fortunately the activities of the
Society have been especially rewarding and I have had the chance to see
pediatric pathology in practice in sites other than North America. Having
the opportunity to see the Society from the perspective of this office
gives me confidence that we are going in the right direction as a force
for research, education and promotion of pediatric pathology. Our Society
for Pediatric Pathology was developed by a group of pathologists with
special knowledge and skills, and since its inception that body of
knowledge has continued to be expanded and modified by clinical and basic
research. In turn, the Society has been and is a forum for the
presentation, discussion, and dissemination of that new knowledge. Our
future as pediatric pathologists and as a unique Society will continue to
be assured if we do as those before us did so ably. Specifically we need
to continue to develop new knowledge and skills, and impress others with
the value that we bring to medicine and society. That means actively
protecting our mandate by creating, discovering, or adopting new knowledge
that is special, and being less reliant on knowledge that has become
common. Simultaneously we should remain cognizant of the scope of our
field of study and practice - it includes the various facets of pathology
from conception to adolescence.
An analogy can be found at your local shopping center. Pediatric
pathologists are for the most part not Walmart equivalents but rather we
are much more like the unique specialty shop. To remain in business
requires innovation and marketing of a special product. That task for our
Society and for pediatric pathologists is not complete and never will be.
As I look at the direction that our Society is taking I see the innovation
through fostering of research, and education of each other and those
beyond the members. We are just beginning to use the new electronic tools
of information dissemination. In other words the intellectual
“retooling” is occurring. The matter of marketing our wares continues
to concern many of us. That will likely always be a challenge for a
comparatively small group of specialists but if we remain the holders of
truly special and valuable knowledge, the challenge should be met. The
Society should and does assist in this struggle, particularly through
formal and informal educational events, but the greatest accomplishments
in retaining our uniqueness are probably to be made by our personal
efforts in our own institutions and communities. In this respect the
Society’s role as an education/information resource is very important.
Fortunately, the Society has a committed membership and a sound committee
structure to keep its direction and functions properly oriented and
I note that I have drifted into corporate lingo, a reflection I suppose
of the managerialist environment in which we practice.
Thanks to all for a great experience!
Proposed Bylaw Changes
Submitted by Virginia Baldwin, MD,
Chair, Membership Committee,
Linda Margraf, MD, Chair, Bylaws Committee,
with committee approval
Following are the suggested revisions to the Articles of Incorporation
and Bylaws of the Society for Pediatric Pathology which the Bylaws
Committee is presenting to be voted on by the membership at the upcoming
spring meeting. Current wording is present with the wording to be
italics and the proposed change in bold
type right after the italicized segment. Where only an addition is
proposed, the added wording is indicated in bold type in the location
Section 1. Types of Membership:
(a) Regular Membership. Pathologists, other physicians or
scientists judged to be predominately and/or productively engaged in the
field of pediatric pathology or allied disciplines are eligible for
regular membership. Regular members are eligible to vote, hold office,
serve on committees, and submit and/or sponsor abstracts for presentation
at scientific meetings of the Society. They shall pay the established
dues, which entitle them to receive the newsletter and include a
subscription the Society’s official journal Pediatric and Developmental
Members in good standing who were previously designated as Life Members
shall continue that status with all the rights and privileges accorded
that category, and may subscribe to the journal Pediatric and
Developmental Pathology at cost. (This category of membership was closed
to additional new members in 1989).
(b) Affiliate Membership. Affiliate Members are those with
qualifications of Regular Members whose permanent residence is outside
North America and who do not wish to become regular members.
are eligible to submit and/or sponsor abstracts for presentation at the
scientific meetings of the Society. They may serve as consultants on
Society committees but may not vote or hold office. They are not obliged
to pay dues but may voluntarily contribute to the Society. Affiliate
members are not eligible to vote or hold office, but may serve as
consultants on Society committees and may submit and/or sponsor abstracts
for presentation at scientific meetings of the Society. They are not
obliged to pay dues but will receive the newsletter and they may obtain a
subscription to Pediatric and Developmental Pathology at cost.
(c) Emeritus Membership. Regular Members in good standing who
have reached their 65th birthday may request that the Secretary transfer
them to emeritus status.
Emeritus Members may submit and/or
sponsor abstracts for presentation at the scientific meetings of the
Society. They may serve on Society committees but are not eligible to vote
or hold office.They are not obliged to pay dues. Emeritus
Members may not vote or hold office, but may serve on Society committees
and may submit and/or sponsor abstracts for presentation at scientific
meetings of the Society. They are not obliged to pay dues but will receive
the newsletter, and they may obtain a subscription to Pediatric and
Developmental Pathology at cost.
Emeritus status may be granted at the discretion of the Council for
reasons of health or other extenuating circumstances prior to a member
reaching his/her 65th birthday.
(d) Honorary Membership. Honorary membership may be conferred on
persons who have rendered distinguished service or who have made major
contributions to pediatric pathology.
Honorary Members are
eligible to submit and/or sponsor abstracts for presentation at the
scientific meetings of the Society. They are not eligible to vote, hold
office or serve on committees. They shall not pay dues. Honorary
Members may not vote, hold office, or serve on Society committees, but
they may submit and/or sponsor abstracts for presentation at scientific
meetings of the Society. They do not pay dues but will receive the
newsletter, and they may obtain a subscription to Pediatric and
Developmental Pathology at cost.
Nominations for Honorary Membership shall be addressed in writing to
the President, to the Secretary or to the Distinctions and Awards
Committee by any Regular Member. These nominations shall be reviewed by
the Membership Committee and appropriate recommendations made to the
Council. Honorary Membership shall be conferred upon recommendation of the
Council and confirmation by a simple majority at the annual Society
(e) Junior Membership. Physicians and other scientists
who are actively engaged in formal training in pathology are eligible for
Junior membership. Junior membership shall be limited to the period of
formal training not to exceed five years.
Junior Members are
eligible to submit abstracts for presentation at scientific meetings of
the Society. They may not vote, serve on committees, or hold office.
Junior Members may not vote, hold office, or serve on Society
committees, but they may submit abstracts for presentation at scientific
meetings of the Society. They shall pay dues at the rate established
for Junior Membership, and these dues entitle them to receive the
newsletter and include a subscription to Pediatric and Developmental
When their professional status changes they must request
that the Secretary transfer them to Regular or Affiliate membership in
order to remain as members. When Junior Members have
completed their training, it is their responsibility to notify the
Secretary of the Society and request Regular or Affiliate membership in
order to remain as members.
Section 4. Resignation and Termination.
Resignation of a member shall be valid only if made in writing to the
Secretary or to the President. Such resignation shall not relieve the
member’s responsibility for any
amount due remaining
financial obligation to the Society.
Failure to pay dues for a period of
two consecutive years
one year, shall cause forfeiture of membership. The Business
Office will provide the Chairman of the Membership Committee with a list
of delinquent members 30 days after the second annual deadline for
membership renewal. The Secretary Chairman
of the Membership Committee shall notify the delinquent member of his
impending action in writing. It is the member’s responsibility to
keep the Society informed of changes of address. Membership may be
reinstated upon payment of dues or reapplication of membership, according
to rules as determined by the Council.
Members may request consideration of temporary modification, partial
deferment or other variations in dues payments by written request, stating
the reasons, to the Chairman of the Membership Committee. Any
modifications will require Council approval.
from the Chair of the Council of the International Paediatric Pathology
Liliane Boccon-Gibod, Chair, IPPA
Reprinted from the September
1997 Newsletter of the International
Paediatric Pathology Association:
At first glance, Pediatric Pathologists in the more highly developed
and still developing countries seem to have different preoccupations:
molecular biology, cytogenetics, bone marrow transplantations for children
with malignancies, gene therapy, iatrogenic diseases, etc, on one side,
tuberculosis, measles, life threatening malformations absence of efficient
medicine or even food on the other side. At the same time, children are
less and less numerous in the more highly developed countries, whereas
birth rate is still extremely high in the developing world with a happily
decreasing infantile mortality rate in most of these countries.
Combination of high birth rate and decreasing infant mortality contributes
to the over population and therefore may delay economic development and
access to health-care and adequate nutrition.
This discrepancy between needs and possibilities has struck me for
years. I remember coming back twenty years ago from giving lectures in
Peru where I had seen the autopsy room filled with children dead from
Meningococcus meningitis or tuberculosis. When back in France, I felt for
a while totally disconnected with the sophisticated medicine we were
Since then, I have learned that pediatric pathologists can take much
benefit of sharing their different experiences. What we can bring to our
colleagues is the product of our thoughts and a short cut through the
different roads we have taken. This may help them avoid our mistakes. We,
pathologists from the over sophisticated countries, can benefit from the
input of our colleagues who deal with these illnesses which used to be
part of our training but which we seldom see now and which our younger
colleagues have never encountered. The vast experience of our colleagues,
their skills, their aptitude to do much with little money should also
teach us modesty and in these times of health cost constraints should help
us be as efficient with less means.
This type of interaction is to me as important as the exchange of all
our research work through proffered papers or publications.
Although the new modes of communications (the web, e-mail fax, etc)
have made exchanges much easier, I still believe in more traditional ways
Nothing can take the place of direct contact, of person-to-person
talks. Nothing will promote more effectively a better understanding than
face-to-face discussion between colleagues. Perhaps this is the single
greatest contribution the IPPA can make. That’s why meeting will still
be with us long after the present generation of modem communication
technology has faded from the screen.
I hope this letter will be a link between the different Pediatric
Pathology Societies all over the world and thus help accomplish better
transmission of Pediatric Pathology. We each have important things to
offer to one another.
OFFICERS OF THE IPPA
Misugi, Japan (1996-1998)
D. Becroft, New Zealand (1998-2000)
R. Drut, Argentina (1994-1996)
L. Boccon-Gibod, France (1994-2000)
V. Anderson, USA (1992-1998)
I. Leuschner, Germany
J. Haas, USA (1996-2002)
D. Benjamin, USA
P Barbet, France and J. Berry, UK
J. Las Heras
Invitation to the Interim
Meeting -- See You in September in Toronto
Glenn Taylor, MD
September 18 & 19 in Toronto, Canada, are the dates to mark on your
calendar for the 1998 SPP Interim Conference being hosted by the Division
of Pathology, Department of Paediatric Laboratory Medicine at The Hospital
for Sick Children and the Department of Laboratory Medicine &
Pathobiology at the University of Toronto. The academic agenda has been
set with a focus on advances in pediatric cardiac/pulmonary pathobiology
and transplant mechanisms.
Arrangements have been made with the Metropolitan Hotel, right in the
heart of downtown Toronto and within walking distance to Sick Kids and the
University. The social agenda includes distinctive Canadian touches.
Toronto is now the 5th largest city in North America offering visitors the
best of everything - including a low dollar exchange rate.
Complete details and registration form will be in the Spring SPP
International Placental Pathology Group
The newly formed branch of the IPPG will hold a meeting on the Friday
before the SPP meeting in Boston, February 27, 1998, Exeter Room.
of Placental Pathology
Immune Associated Pathology in Recurrent
Pregnancy Compromise -- Carolyn Salafia, M.D.
Placenta in HIV Infection -- Edwina Popek, D.O.
Utero-Placental Vessels in Fetal Growth -- Jorge Las Heras,
IPPG Business Meeting
Informal Social Gathering
Anyone interested may attend. For additional information please contact:
Jorge Las Heras, M.D., Ph.D., Faculty of Medicine, University of Chile,
Independencia 1027, Santiago, Chile; FAX: 56-2-777-4890; E-mail: firstname.lastname@example.org
Website Editor Search
Beverly B. Rogers, MD
Chairman Publications Committee
The Society for Pediatric Pathology is taking applications for the
Editor of the SPP Web Page. The Editor will be responsible for identifying
a site for the Web Page, with adequate facilities for maintenance and
expansion. The Editor should be a member of the SPP and will work closely
with the Publications Committee of the SPP to define future goals for the
Web Page. He/she must be someone who is familiar with the technology and
be responsible for placing items on the Website. Persons interested in
applying for this position should forward a letter of application and a
curriculum vitae by February 10, 1998 to: Beverly B. Rogers, MD,
Department of Pathology, Children’s Medical Center, 1935 Motor Street,
Dallas, TX 75235, Fax: 214/640-6199, E-mail: email@example.com
and Tissue Bank for Developmental Disorders
Maria M. Rodriguez, MD
The University of Miami has been funded by the National Institute of
Child Health and Human Development in order to develop the Brain and
Tissue Bank for Developmental Disorders. The main purpose of the Bank is
to support research leading to an understanding of the causes of
developmental disabilities, improved outcome of affected individuals, and
prevention of those problems in future generations.
The Bank has available autopsy and biopsy tissue on selected disorders
of the brain and nervous system. The disorders include: chromosomal
anomalies, inborn errors of metabolism, syndromes associated with
developmental delay, disorders of cerebral cortex and motor development,
such as dystrophy, mitochondrial encephalomyopathies, tuberous sclerosis,
neurofibromatosis, fragile X syndrome, X-linked MR syndromes and dystonia.
We also collect tissues from normal controls.
The specific requests related to tissue processing, other diseases or
case enrollment, please call Dr. Carol K. Petito, PI, University of Miami,
800/59-BRAIN or 305/243-6834. You can also visit our web site at
www.med.miami.edu/BTB or e-mail us at firstname.lastname@example.org.
We encourage your participation in the worthwhile endeavor through
contribution of unique cases as well as scientific requests from the Bank.
The Children’s Hospital of Michigan, a growing, free standing
constituent of the Detroit Medical Center, is seeking a third Pediatric
Pathologist to complement its staff. The applicant should be board
certified (or qualified in anatomic pathology, and pediatric pathology).
Additional qualification in diagnostic renal pathology is desirable.
Responsibilities are primarily diagnostic anatomic pathology service but
include research appropriate to a university based Children’s Hospital
Laboratory, and teaching in the Department of Pathology at the Wayne State
University School of Medicine. The incumbent will be appointed to the
Pathology faculty at an appropriate level. The Children’s Hospital of
Michigan and the Wayne State University are equal opportunity employers.
For further information contact: Joel Haas, MD, Chief of Pathology and
Laboratory Medicine, Children’s Hospital Michigan, 3901 Beaubien
Boulevard, Detroit, MI 4820; 313/745-5315; Fax 313/993-8754; E-mail: JEHAAS@med.wayne.edu
CHILDREN’S HOSPITAL OF PITTSBURGH
The Department of Pediatric Pathology at Children’s Hospital of
Pittsburgh is accepting applications from qualified recent graduates who
want to be a part of an exciting and dynamic program with a major focus on
pediatric neoplastic diseases, infectious diseases, and transplantation
biology. The applicant should be Board certified (or equivalent) in
Anatomic Pathology or AP/CP and be qualified or eligible for the Pediatric
Pathology Special Certification. The individual should have an interest in
general pediatric pathology, the pathology of the surgical subspecialities
and transplant pathology. A specific service interest such as pediatric
dermatopathology would be an added asset The candidate should have the
ability to embark on and persue a research program in pediatric disease,
preferably with a focus on the molecular aspects. The Department is
involved in extensive interaction with clinicans and teaching of medical
students, housestaff and fellows.
Academic rank and salary will be at the Assistant Professor level (nontenured).
Candidates shoud direct their letter of application with a CV and names of
three references to: Ronald Jaffe, MD, Department of Pathology,
Children’s Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsurgh, PA
PEDIATRIC AND PERINATAL
PATHOLOGY ASSOCIATES, P.S.C.
Pediatric and Perinatal Pathology Associates, P.S.C. has a full time
position available for a pediatric pathologist. This group services Kosair
Children’s Hospital, Louisville, Kentucky, a 263 bed, full-service
pediatric facility which is affiliated with the University of Louisville.
The group is responsible for approximately 5000 surgical specimens and 100
autopsies per year. The applicant should be board certified in pathology
(AP or AP/CP) and certified or eligible in pediatric pathology. Expertise
in perinatal pathology is desirable. For further information contact: John
J. Buchino, MD, Chief of Pathology, Kosair Children’s Hospital, PO Box
35070, Louisville, KY 40232; 502/629-7900; Fax: 502/629-7906; E-mail: email@example.com
University of Tennessee Announces
Physicians Executive MBA Program to Train Doctors as Business Leaders
The University of Tennessee’s College of Business, a national leader
in Executive MBA programs, has launched their most innovative executive
MBA program to date: a twelve month Physicians EMBA (PEMBA) program
designed to train doctors to be business leaders for the health care
market. The program, which is open to 22-28 selected physicians, will be
offered annually beginning in January 1998.
UT’s cutting-edge PEMBA program will utilize breakthrough “distance
learning technologies” to allow the participants to maintain their
current medical practices while limiting ravel time and costs. The
centerpiece of the program will be forty “Cyber Classes” held over the
Internet at the physician’s own work or home PC via state-of-the-art
audio and data conferencing. These real time, interactive, instructor-led
classes will completely replicate the true classroom experience.
Participants will also be given assignments over the Internet to be
completed at their schedule’s convenience. Rounding out the PEMBA
learning experience will be four week long Residence Periods of intensive
training and course work held at the University of Tennessee’s Knoxville
campus during the twelve month program. Realizing that today’s
physicians require business and managerial skills in addition to medical
expertise, UT has designed the PEMBA program to provide physicians the
skills necessary to succeed on the business level of the changing health
According to Dr. Michael Stahl, Associate Dean of UT’s College of
Business Administration and Program Director for the Physicians EMBA
program, “Physicians are the decision-makers in the expenditure of
health care dollars and yet they are under-represented in the management
level of health care organizations. This program will enable physicians to
develop the skills which will allow them to become better business
Stahl also notes that “The UT College of Business Administration,
with its core competency of designing customized, inter-disciplinary MBA
programs, is uniquely qualified to deliver a customized Physician EMBA
program that will provide key skills and knowledge to these potential
The course of study will focus on three main areas including conceptual
skills, interpersonal skills and technical/analytical skills. Participants
will be exposed to a variety of business activities from team leadership
to financial statement analysis.
The University of Tennessee at Knoxville, an innovator in MBA programs,
introduced a national model for functionally integrated MBA programs in
1991 and its first Executive MBA program in 1993. Since then, UT gas
pioneered several other successful EMBA programs, including an
International EMBA program designed for Taiwanese executives. For more
information on the UT PEMBA program, please contact Dr. Michael Stahl at
423/974-5061 or via E-mail: firstname.lastname@example.org or visit the program’s
Internet homepage at http://www.pemba.utk.edu.
Report from the Nominating
The Nominating Committee has recommended the following candidates for the
Joe C. Rutledge, MD
Deborah Perry, MD
Cheryl M. Coffin,
Carole A. Vogler, MD
Future Pediatric Pathology
1998 Annual Meeting, Boston, MA., February 28-March 1
1998 Interim Meeting, Toronto, ON., September 18-19
1999 Annual Meeting, San Francisco, CA., March 19-20
The XXII International Congress of the IAP: Nice, France, October
The Preliminary program is as follows:
Surgical pediatric pathology (slide seminar); L. Boccon-Gibod, J.
Breast lesions in children and adolescents (short course); F.A. Tavassoli
Renal tumors in children and adults (short course); J.B. Beckwith, J.
Cholestasis in children (IPPA companion meeting); K Misugi, R Kaschula
Lung pathology in children (symposium); E. Cutz, J.T. Stocker
Soft tissue tumors in children (short course); L. P. Dehner, P. Thorner
Genetics in feto-pathology (symposium); D. Kalousek, D. Gaillard
Feto-placental pathology (slide seminar); J. Keeling, D. Gaillard
PPS Annual Meetings
44th Annual Meeting, September 17-19, 1998, Lorient, France
45th Annual Meeting, to be announced, 1999, Belfast, Northern Ireland
46th Annual Meeting, to be announced, 2000, Edinburgh, Scotland
47th Annual Meeting, to be announced, 2001, Rome, Italy
IPPA Advanced Course in Paediatric Pathology
1998, Guidel, France, September 19-25, (Local organizer, F. Labbe)
1999, N. Ireland, Dates to be announced, (Local organizers, D. O’Hara
and C. Thornton)
Sociedad LatinoAmericana de Patologia Pediatrica
Panama City, 1998
For additional information, Prof. Moises Espino Duran (President of the
SLAPPA), Hospital Santa Fe 2o piso Consultorio No 15, Apartado 7444 Panama
5 Panama, Panama y Calle 3a No 12, Parque Lefevre 7444 Panama. FAX:
507/263-7788, E-mail: email@example.com
The Aspen Conference on Pediatric Disease Celebrates its Twentieth Annual
Meeting The Pathology of Tumors in Children
The Institute for Pediatric Medical Education and the Society for
Pediatric Pathology (SPP) will jointly sponsor a course on the pathology
of tumors in children as part of the 20th Annual Aspen Conference on
Pediatric Disease. The week-long seminar will be held at the Gant in
Aspen, CO from August 3-7, 1998 under the direction of Drs. Louis P.
Dehner and Frederic B. Askin.
This course is designed primarily for general and pediatric
pathologists but will be of interest to pediatric surgeons, radiologists,
and oncologists. Presentations will include discussions of the role of the
pediatric pathologist in neoplasia in children, neoplastic syndromes, the
handling of renal and other tumors, and the clinical and pathologic
features of pulmonary, CNS, liver, ovarian, testicular, and bone tumors as
well as neuroblastomas, PNETs, and inflammatory pseudotumors, among
others. A microscopic slide set of 24 cases will be sent to participants
prior to the conference, and the cases will be discussed in detail during
a series of slide seminars. Participants may also submit cases for a
“Stump the Faculty” session. Faculty members include, J.B. Beckwith,
L.P. Dehner, F.B. Askin, J.T. Stocker, L. Becker, and R. Shikes. Course
participants will also receive a 250-300 page syllabus including
conference presentations and slide seminar discussion.
This course, through the SPP is accredited by the Accreditation Council
for Continuing Medical Education (ACCME). The SPP certified that this CME
activity meets the criteria for 29 credit hours in category 1 for
Physician’s Recognition Award of the American Medical Association.
A special reduced tuition rate is available for members of the SPP. For
further information, contact the Institute for Pediatric Medical Education
(IPME), 6604 Landon Lane, Bethesda, MD 20817. Tel & Fax: 301/229-8338.
A second, more clinically oriented week of “Pediatric Hepatology and
Liver Transplantation” will be held from July 26-31 at the Gant in
Aspen. Information on this seminar can also be obtained by contacting the
IPME at the above address.